Texas is scheduled to execute Jamaal Howard on Wednesday, making it the first US execution since Christa Pike survived two doses of pentobarbital in Tennessee last week. Pike regained consciousness Tuesday, has pneumonia, and cannot move her arms. Tennessee's governor has barred further lethal injections for the rest of the year and ordered a probe into why the execution failed. Howard's legal team filed an emergency motion with Texas's court of criminal appeals arguing the state faces "a similar risk" — that its pentobarbital supply is degraded past the pharmacopeia's beyond-use dates. The court denied the stay request Wednesday. His attorneys had also filed requests for information about the specific drugs Texas plans to use, but the attorney general's opinion is not expected until after the execution, meaning Howard cannot litigate whatever the state decides about releasing that information. The timing is structurally important. A state is proceeding with the identical drug protocol that just failed catastrophically in a neighboring state, while simultaneously blocking the condemned man's lawyers from obtaining information about the drug's quality before the scheduled execution. The Fifth Circuit Court of Appeals declined a separate request to halt the execution last week. Howard, 46, was convicted of capital murder in 2001 for fatally shooting 42-year-old convenience store clerk Vickie Swartout during a robbery in Silsbee, Texas. His legal team has separately argued he is intellectually disabled and thus ineligible for the death penalty under the Supreme Court's 2002 ruling in Atkins v. Virginia — a claim that has not been resolved. Pike's botched execution was the second in Tennessee this year. Speculation centers on the quality of the pentobarbital itself, and Pike's lawyers had previously warned that her blood disorder would complicate intravenous drug delivery. The fact that the drug failed across two doses — not merely caused pain but failed to accomplish its stated purpose — raises questions about the entire compounded pentobarbital supply chain that multiple states rely on. The core extraction here runs in two directions. States maintain execution secrecy laws that shield drug suppliers, compounding pharmacies, and dosage details from public scrutiny — arguing supplier protection. The condemned and their counsel bear the full information asymmetry: they cannot test, inspect, or even identify the substance that will be used to kill them. When the drug fails, the state suffers embarrassment; the person on the gurney suffers physically. Texas officials did not return a request for comment Wednesday morning. The state has executed more people than any other since reinstating the death penalty and has shown no institutional inclination to pause its schedule based on failures in other jurisdictions.
